Literature DB >> 19605475

Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection.

Christina F Thobakgale1, Andrew Prendergast, Hayley Crawford, Nompumelelo Mkhwanazi, Danni Ramduth, Sharon Reddy, Claudia Molina, Zenele Mncube, Alasdair Leslie, Julia Prado, Fundi Chonco, Wendy Mphatshwe, Gareth Tudor-Williams, Prakash Jeena, Natasha Blanckenberg, Krista Dong, Photini Kiepiela, Hoosen Coovadia, Thumbi Ndung'u, Bruce D Walker, Philip J R Goulder.   

Abstract

A broad Gag-specific CD8(+) T-cell response is associated with effective control of adult human immunodeficiency virus (HIV) infection. The association of certain HLA class I molecules, such as HLA-B*57, -B*5801, and -B*8101, with immune control is linked to mutations within Gag epitopes presented by these alleles that allow HIV to evade the immune response but that also reduce viral replicative capacity. Transmission of such viruses containing mutations within Gag epitopes results in lower viral loads in adult recipients. In this study of pediatric infection, we tested the hypothesis that children may tend to progress relatively slowly if either they themselves possess one of the protective HLA-B alleles or the mother possesses one of these alleles, thereby transmitting a low-fitness virus to the child. We analyzed HLA type, CD8(+) T-cell responses, and viral sequence changes for 61 mother-child pairs from Durban, South Africa, who were monitored from birth. Slow progression was significantly associated with the mother or child possessing one of the protective HLA-B alleles, and more significantly so when the protective allele was not shared by mother and child (P = 0.007). Slow progressors tended to make CD8(+) T-cell responses to Gag epitopes presented by the protective HLA-B alleles, in contrast to progressors expressing the same alleles (P = 0.07; Fisher's exact test). Mothers expressing the protective alleles were significantly more likely to transmit escape variants within the Gag epitopes presented by those alleles than mothers not expressing those alleles (75% versus 21%; P = 0.001). Reversion of transmitted escape mutations was observed in all slow-progressing children whose mothers possessed protective HLA-B alleles. These data show that HLA class I alleles influence disease progression in pediatric as well as adult infection, both as a result of the CD8(+) T-cell responses generated in the child and through the transmission of low-fitness viruses by the mother.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19605475      PMCID: PMC2748050          DOI: 10.1128/JVI.00921-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation.

Authors:  P J Goulder; C Pasquier; E C Holmes; B Liang; Y Tang; J Izopet; K Saune; E S Rosenberg; S K Burchett; K McIntosh; M Barnardo; M Bunce; B D Walker; C Brander; R E Phillips
Journal:  Immunol Lett       Date:  2001-11-01       Impact factor: 3.685

2.  HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.

Authors:  Margaret E Feeney; Yanhua Tang; Katja Pfafferott; Kathleen A Roosevelt; Rika Draenert; Alicja Trocha; Xu G Yu; Cori Verrill; Todd Allen; Corey Moore; Simon Mallal; Sandra Burchett; Kenneth McIntosh; Stephen I Pelton; M Anne St John; Rohan Hazra; Paul Klenerman; Marcus Altfeld; Bruce D Walker; Philip J R Goulder
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

3.  Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.

Authors:  Masahiro Kobayashi; Hiroko Igarashi; Akiko Takeda; Moriaki Kato; Tetsuro Matano
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant.

Authors:  Arne Schneidewind; Yanhua Tang; Mark A Brockman; Elizabeth G Ryland; Jacqueline Dunkley-Thompson; Julianne C Steel-Duncan; M Anne St John; Joseph A Conrad; Spyros A Kalams; Francine Noel; Todd M Allen; Celia D Christie; Margaret E Feeney
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

5.  Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.

Authors:  Andrew Prendergast; Wendy Mphatswe; Gareth Tudor-Williams; Mpho Rakgotho; Visva Pillay; Christina Thobakgale; Noel McCarthy; Lynn Morris; Bruce D Walker; Philip Goulder
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

6.  Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.

Authors:  Victor Sanchez-Merino; Melissa A Farrow; Frank Brewster; Mohan Somasundaran; Katherine Luzuriaga
Journal:  J Infect Dis       Date:  2008-01-15       Impact factor: 5.226

Review 7.  International perspectives, progress, and future challenges of paediatric HIV infection.

Authors:  Andrew Prendergast; Gareth Tudor-Williams; Prakash Jeena; Sandra Burchett; Philip Goulder
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

8.  Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.

Authors:  Tetsuro Matano; Masahiro Kobayashi; Hiroko Igarashi; Akiko Takeda; Hiromi Nakamura; Munehide Kano; Chie Sugimoto; Kazuyasu Mori; Akihiro Iida; Takahiro Hirata; Mamoru Hasegawa; Takae Yuasa; Masaaki Miyazawa; Yumiko Takahashi; Michio Yasunami; Akinori Kimura; David H O'Connor; David I Watkins; Yoshiyuki Nagai
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

9.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.

Authors:  Paul A Goepfert; Wendy Lumm; Paul Farmer; Philippa Matthews; Andrew Prendergast; Jonathan M Carlson; Cynthia A Derdeyn; Jianming Tang; Richard A Kaslow; Anju Bansal; Karina Yusim; David Heckerman; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2008-04-21       Impact factor: 14.307

10.  High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis.

Authors:  Wendy Mphatswe; Natasha Blanckenberg; Gareth Tudor-Williams; Andrew Prendergast; Christina Thobakgale; Nompumelelo Mkhwanazi; Noel McCarthy; Bruce D Walker; Photini Kiepiela; Philip Goulder
Journal:  AIDS       Date:  2007-06-19       Impact factor: 4.177

View more
  35 in total

1.  Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.

Authors:  Vanessa L Naidoo; Jaclyn K Mann; Christie Noble; Emily Adland; Jonathan M Carlson; Jake Thomas; Chanson J Brumme; Christina F Thobakgale-Tshabalala; Zabrina L Brumme; Mark A Brockman; Philip J R Goulder; Thumbi Ndung'u
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  Short communication: CD8(+) T cell polyfunctionality profiles in progressive and nonprogressive pediatric HIV type 1 infection.

Authors:  Christina F Thobakgale; Hendrik Streeck; Nompumelelo Mkhwanazi; Zenele Mncube; Lungile Maphumulo; Fundisiwe Chonco; Andrew Prendergast; Gareth Tudor-Williams; Bruce D Walker; Philip J R Goulder; Marcus Altfeld; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2011-03-21       Impact factor: 2.205

3.  Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.

Authors:  Jaclyn K Wright; Vladimir Novitsky; Mark A Brockman; Zabrina L Brumme; Chanson J Brumme; Jonathan M Carlson; David Heckerman; Bingxia Wang; Elena Losina; Mopo Leshwedi; Mary van der Stok; Lungile Maphumulo; Nompumelelo Mkhwanazi; Fundisiwe Chonco; Philip J R Goulder; Max Essex; Bruce D Walker; Thumbi Ndung'u
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection.

Authors:  Ling Yue; Heather A Prentice; Paul Farmer; Wei Song; Dongning He; Shabir Lakhi; Paul Goepfert; Jill Gilmour; Susan Allen; Jianming Tang; Richard A Kaslow; Eric Hunter
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

5.  Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Rui Wang; Lauren Margolin; Jeannie Baca; Sikhulile Moyo; Rosemary Musonda; M Essex
Journal:  Virology       Date:  2010-05-04       Impact factor: 3.616

6.  CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.

Authors:  Catherine K Koofhethile; Zaza M Ndhlovu; Christina Thobakgale-Tshabalala; Julia G Prado; Nasreen Ismail; Zenele Mncube; Lungile Mkhize; Mary van der Stok; Nonhlanhla Yende; Bruce D Walker; Philip J R Goulder; Thumbi Ndung'u
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

Review 7.  Host genes associated with HIV/AIDS: advances in gene discovery.

Authors:  Ping An; Cheryl A Winkler
Journal:  Trends Genet       Date:  2010-02-10       Impact factor: 11.639

8.  Immunodominant HIV-1-specific HLA-B- and HLA-C-restricted CD8+ T cells do not differ in polyfunctionality.

Authors:  Nompumelelo Mkhwanazi; Christina F Thobakgale; Mary van der Stok; Shabashini Reddy; Zenele Mncube; Fundisiwe Chonco; Bruce D Walker; Marcus Altfeld; Philip J R Goulder; Thumbi Ndung'u
Journal:  Virology       Date:  2010-07-17       Impact factor: 3.616

Review 9.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  HCV adaptations to altered CD8+ T-cell immunity during pregnancy.

Authors:  Aryn A Price; Arash Grakoui; Jonathan R Honegger
Journal:  Future Virol       Date:  2014-04-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.